FRI0326 Efficacy and Safety of Tabalumab, an Anti-B Cell...

Annals of the Rheumatic Diseases 2014 / 06 Vol. 73; Iss. Suppl 2

FRI0326 Efficacy and Safety of Tabalumab, an Anti-B Cell Activating Factor Monoclonal Antibody, in Patients with Rheumatoid Arthritis Who HAD an Inadequate Response to Methotrexate Therapy: Results from A Phase 3 Multicenter, Randomized, Double-Blind Study

Smolen, J.S., Weinblatt, M.E., van der Heijde, D., Rigby, W.F., van Vollenhoven, R., Bingham, C.O., Veenhuizen, M., Gill, A., Zou, H., Komocsar, W., Berclaz, P.-Y., Ortmann, R., Lee, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
73
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2014-eular.1535
Date:
June, 2014
File:
PDF, 73 KB
english, 2014
Conversion to is in progress
Conversion to is failed